Cite
MLA Citation
R. Bannerji et al.. “POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL.” Hematological oncology, vol. 39, n.d., p. n/a. http://access.bl.uk/ark:/81055/vdc_100133622930.0x000024